Our latest press releases, media appearances and news commentary.
Medicines Discovery Catapult announce that it has been awarded government seedcorn funding; provided through UK Research and Innovation’s flagship £236m Strength in Places Fund, along with project partner Cheshire & Warrington Local Enterprise Partnership (LEP).
Cheshire East Council has welcomed the announcement on 4 August 2020, of £15.5 million of the Getting Building Fund for investment in schemes in Cheshire and Warrington.
The Alderley Park Lighthouse Lab, which was launched to rapidly expand COVID-19 testing capacity, has processed more than 1 million test samples since opening.
Consortia are enabling drug discovery in areas that individual organizations are unable to support alone because of the high risk or the need to pool information.
The Psychiatry Consortium is again seeking project proposals which focus on the validation of novel molecular drug-targets.
This week the Medicines Discovery Catapult has welcomed three new Board Members.
Medicines Discovery Catapult, Retrogenix and Peak Proteins collaborate to identify target receptors for COVID-19.
Sites in Milton Keynes, Glasgow and Alderley Park in Cheshire are now live and are already testing thousands of patient samples for coronavirus (COVID-19) each day.
The second mega-lab at Alderley Park in Cheshire has begun to test thousands of patient samples a day for coronavirus.
The Government announced the establishment of large scale national COVID-19 hub laboratories across the UK.
See how we can help support you with your next drug discovery project.
Speak to us